DV
Dividend Vision

DXR — Daxor Corporation

Daxor Corporation (DXR)

Its deepest 1-year drawdown was 39.9%.

Daxor Corporation develops and markets medical diagnostic equipment, specifically the BVA-100 Blood Volume Analyzer used in conjunction with Volumex, a radiopharmaceutical diagnostic kit for measuring human blood volume. The company does not currently distribute dividends to shareholders. This security may appeal to investors seeking exposure to specialized medical instrumentation and biotechnology operations rather than current income.

DXR key facts

Asset type
Stock
Asset class
Equity
Inception date
11/05/1984
Distribution frequency
Annual
5-year average yield
0.52
Last close
$10.40
Market cap
$63,636,640
Average volume
160.0
Ex-dividend date
01/05/2018
Payment date
01/12/2018
Beta
0.257
Payout ratio
0.0
P/E ratio
6.6463
Forward P/E
64.5161
EPS
$1.64